Market Closed - Euronext Paris 11:35:27 2024-06-14 am EDT 5-day change 1st Jan Change
4.01 EUR -9.17% Intraday chart for GENFIT -17.32% +13.28%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading MT
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading MT
HC Wainwright Raises Genfit SA Price Target to $13 From $11, Maintains Buy Rating MT
Genfit S.A. Announces the Successful Corporate Milestone with U.S. FDA Accelerated Approval of Ipsen's Iqirvo for Primary Biliary Cholangitis CI
Genfit Partner Ipsen Gets FDA Accelerated Approval for Primary Biliary Cholangitis Treatment MT
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug RE
US FDA approves Genfit and Ipsen's liver disease drug RE
European Equities Traded in the US as American Depositary Receipts Lower in Monday Trading MT
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading MT
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading MT
European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3% MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4% MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading MT
Chart GENFIT
More charts
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.01 EUR
Average target price
9.475 EUR
Spread / Average Target
+136.28%
Consensus
  1. Stock Market
  2. Equities
  3. GNFT Stock
  4. News GENFIT
  5. European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading